Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Resveratrol Supplementation on Inflammatory Biomarkers and Cardiometabolic Parameters in Community-dwelling Adults. (RESINCA-trial)

NCT07395921 is registered in ClinicalTrials.gov with Center for Research and Innovation Viña Concha y Toro as lead sponsor.

NCT NCT07395921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07395921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Resveratrol Supplementation on Inflammatory Biomarkers and Cardiometabolic Parameters in Community-dwelling Adults. (RESINCA-trial)
Lead sponsor
Center for Research and Innovation Viña Concha y Toro
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 1, 2026
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antioxidant capabilities, antioxidant status, inflammation, cardiometabolic health indicators, inflammaging, inflammation biomarkers